Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
New government guide covers most of the bases
Most doctors are aware of the importance of
obtaining consent from patients for examination and treatment. Yet many
are uncertain about what this means and fear that their instincts about
what is right may not be enough to protect them from legal challenge. The result of this uncertainty may be reluctance to treat in a difficult case or the expenditure of much time and effort avoiding allegations that adequate consent has not been obtained. Sensitivity to
consent has thus been a two edged sword: while patients have been
protected from indefensible paternalism, they have at the same time
been subjected to unnecessary formalities. In the case of psychiatric
treatment, extreme sensitivity to consent has, in some jurisdictions,
resulted in the denial of treatment to patients who desperately need it.
In the long running consent saga, the courts have been caught between a
desire to protect the rights of patients The Department of Health has now published an important and
exceptionally useful guide to consent for examination or
treatment.2 The last time the department issued guidance
on this issue was over a decade ago, since when there have been
important developments. One of these is the introduction into domestic
English law of the provisions of the European Convention on Human
Rights, a body of principles which is likely to touch virtually every
area of the law.3 Consent is a human rights issue, in that
respect for bodily integrity and privacy are values that are central to any theory of consent and are, of course, central values in the convention. The shape of English law on this issue is therefore going
to be affected by European jurisprudence, although precisely how this
will occur remains to be seen.
The guide is admirably clear, setting out how to obtain consent and in
what circumstances it might be proper to proceed without it. On the
issue of what information needs to be conveyed to the patient for
proper consent to be given, the department points out that the case law
is still evolving. This is true, and the advice that is given on this
topic is helpful and correct, but it highlights a central tension in
this matter that continues to frustrate doctors.
Under the long accepted Bolam test,4 the standard by
which disclosure to patients is judged is that which would be endorsed by a reasonable or responsible body of medical opinion. The test, therefore, was whether what a doctor told the patient met the standards
expected of itself by the medical profession. Now, in cases such as
Bolitho5 and Pearce,6 the courts have said that they will depart from the professional practice approach if they
see fit, the ultimate legal test being what the court itself thinks was
a reasonable amount of information to give the patient. But how, one
might wonder, is a doctor going to be able to reach that decision?
Doctors cannot guess what the courts are going to say. All that they
can do is ask themselves: Is this what my professional peers would
consider the proper thing to do? This leaves an element of doubt, which
no amount of guidance from the Department of Health will ever be able
to dispel. (The answer, of course, is simple and unfashionable: the
medical profession should be left some areas where it can safely rely
on its own collective judgment and wisdom.)
Disclosure of risk is one of the few remaining areas of
uncertainty, as the guide clearly shows. Although there are consent points on which courts in the United Kingdom have still to rule, the
general contours of the law are firmly in place. Patient autonomy has
triumphed, and people may now decline medical intervention for whatever
reason they choose. Advance directives must be followed, except
possibly in relation to basic care; refusal of food must be respected;
and care must be taken not to exceed the bounds of what is authorised.
All of this will strike most contemporary medical practitioners as
eminently reasonable, the only question being why it has taken the law
so long to get to there.
University of Edinburgh, Edinburgh EH8 9YL
a role with which the law
feels quite comfortable
and a reluctance to impose impossible
requirements on the medical profession. In the United Kingdom the
courts have generally tried to control consent based actions1 but have acknowledged that the competent adult
ultimately has the right to refuse a medical intervention if he or she
so desires. The controversy and legal uncertainty, then, has largely focused on the disclosure of risk, on cases involving children and
those who are mentally compromised, and on issues of the limits of
consent (does consent to a surgical procedure, for example, permit the
use of excised tissue for research?)
Footnotes
Competing interest: AMcCS is vice chairman of the Human Genetics Commission, which is located within the Department of Health.
| 1. | Sidaway v Board of Governors of the Bethlem Royal Hospital [1985] Appeal Cases 871. |
| 2. | Department of Health. Reference guide to consent for examination or treatment. London: Department of Health, 2001. on www.doh.gov.uk/consent |
| 3. | Human Rights Act 1998. London: Stationery Office, 1998. |
| 4. | Bolam v Friern Hospital Management Committee [1957] 2 All ER 118. |
| 5. | Bolitho v City and Hackney Health Authority [1997] 4 All ER 771. |
| 6. | Pearce v United Bristol Healthcare NHS Trust (1999) Butterworths Medical Law Reports 118. |
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+